Zhang et al. demonstrated that in patients without T2DM, plasma glucose levels are positively correlated with MPO levels, which suggests that the latter may play an atherogenic role in patients with higher blood glucose [22]. The gene discussed is MPO; the disease is type 2 diabetes mellitus.